Identifying predictive biomarkers for long term response on immunotherapy in non-small cell lung cancer (NSCLC)

Original language	English
Publication status	Published - 9 Sept 2022
Event	ESMO Congress 2022 - Paris, France Duration: 9 Sept 2022 → 13 Sept 2022 https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2022/programme

Conference

Conference	ESMO Congress 2022
Country/Territory	France
City	Paris
Period	9/09/22 → 13/09/22
Internet address	https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2022/programme

Handle.net

• Persistent link

Projects

Projects per year 2020 2020 2021 2024

• 2 Finished

Projects per year

• FWOAL1006: Creation of a 3D CRiMe scene to unravel Cytotoxicity Resistant Mechanisms in non-small cell lung cancer

  Goyvaerts, C. (Administrative Promotor)

  1/01/21 → 31/12/24

  Project: Fundamental

  • Lung 100%
  • Immunotherapy 63%
  • Non Small Cell Lung Cancer 33%
  • Programmed Death-Ligand 1 32%
  • Cytotoxic T Cell 20%

• AIIFUND64: Creation of a 3D CRiMe scene to unravel Cytotoxic T cell Resistant Mechanisms

  Goyvaerts, C. (Administrative Promotor)

  1/04/20 → 28/02/22

  Project: Fundamental

  • Lung 100%
  • Immunotherapy 64%
  • Cytotoxic T Cell 40%
  • Programmed Death-Ligand 1 35%
  • Tumor Spheroid 22%

Research output

Research output per year 2022 2022 2022

• 1 Meeting abstract (Journal)

Research output per year

Research output per year

• 1096P Identifying predictive biomarkers for long term response on immunotherapy in non-small cell lung cancer (NSCLC)

  Decoster, L., De Ridder, K., Nazari, S., Giron, P., Vekens, K. L. K. & Goyvaerts, C., 9 Sept 2022, In: Annals of Oncology. 33, 7, p. 1052-1052 1 p.

  Research output: Contribution to journal › Meeting abstract (Journal)

  • Immunotherapy 100%
  • Biological Marker 100%
  • Non Small Cell Lung Cancer 100%
  • Immune Checkpoint Inhibitor 100%
  • Lung 100%

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

De Ridder, K., Nazari, S., Decoster, L., Giron, P., Vekens, K. L. K., & Goyvaerts, C. (2022). Identifying predictive biomarkers for long term response on immunotherapy in non-small cell lung cancer (NSCLC). Poster session presented at ESMO Congress 2022, Paris, France.

De Ridder, Kirsten ; Nazari, Sohrab ; Decoster, Lore et al. / Identifying predictive biomarkers for long term response on immunotherapy in non-small cell lung cancer (NSCLC). Poster session presented at ESMO Congress 2022, Paris, France.

@conference{f36412cf672c4ce0af6baf055a27cd99,

title = "Identifying predictive biomarkers for long term response on immunotherapy in non-small cell lung cancer (NSCLC)",

author = "\{De Ridder\}, Kirsten and Sohrab Nazari and Lore Decoster and Philippe Giron and Vekens, \{Karolien Leona K\} and Cleo Goyvaerts",

year = "2022",

month = sep,

day = "9",

language = "English",

note = "ESMO Congress 2022 ; Conference date: 09-09-2022 Through 13-09-2022",

url = "https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2022/programme",

}

De Ridder, K, Nazari, S, Decoster, L, Giron, P, Vekens, KLK & Goyvaerts, C 2022, 'Identifying predictive biomarkers for long term response on immunotherapy in non-small cell lung cancer (NSCLC)', ESMO Congress 2022, Paris, France, 9/09/22 - 13/09/22.

Identifying predictive biomarkers for long term response on immunotherapy in non-small cell lung cancer (NSCLC). / De Ridder, Kirsten; Nazari, Sohrab; Decoster, Lore et al.
2022. Poster session presented at ESMO Congress 2022, Paris, France.

Research output: Unpublished contribution to conference › Poster

TY - CONF

T1 - Identifying predictive biomarkers for long term response on immunotherapy in non-small cell lung cancer (NSCLC)

AU - De Ridder, Kirsten

AU - Nazari, Sohrab

AU - Decoster, Lore

AU - Giron, Philippe

AU - Vekens, Karolien Leona K

AU - Goyvaerts, Cleo

PY - 2022/9/9

Y1 - 2022/9/9

M3 - Poster

T2 - ESMO Congress 2022

Y2 - 9 September 2022 through 13 September 2022

ER -

De Ridder K, Nazari S, Decoster L, Giron P, Vekens KLK, Goyvaerts C. Identifying predictive biomarkers for long term response on immunotherapy in non-small cell lung cancer (NSCLC). 2022. Poster session presented at ESMO Congress 2022, Paris, France.